Literature DB >> 19730951

Long-term follow-up evaluation for more than 10 years after endoscopic treatment for postoperative bile duct strictures.

Yasuhisa Kuroda1, Toshio Tsuyuguchi, Yuji Sakai, Sudhamshu K C, Takeshi Ishihara, Taketo Yamaguchi, Hiromitsu Saisho, Osamu Yokosuka.   

Abstract

BACKGROUND: Endoscopic stent therapy is routinely used to treat postoperative bile duct strictures. However, no studies have detailed long-term follow-up evaluation for more than 10 years.
METHODS: This study enrolled 22 consecutive patients with a diagnosis of postoperative bile duct strictures from 1987 to 2006. Cases involving digestive tract reconstruction were excluded. Dilation was performed after passage of a guidewire through the stricture followed by temporary stent placement. The final objective was to achieve stent free status after sufficient dilation. The stent was removed when the cholangiogram showed apparent resolution of the stricture. If stent removal was not possible within 12 months, the authors proposed a surgical treatment option.
RESULTS: Initial therapy was performed for 21 patients (21/ 22, 95%). The remaining patient had complete occlusion, which required surgical repair. For 3 of the 21 cases, guidewire passage through the narrow stricture under fluorographic guidance alone was impossible. However, visualization by peroral cholangioscope enabled passage of the guidewire in all three cases. In two cases, the stricture persisted longer than 12 months, rendering stent removal impossible. Therefore, stent removal within 12 months was achieved in 90% of the cases (19/21). Two patients requested prolonged stenting in lieu of the authors' proposal to repeat the surgery. This resulted in sufficient dilation after an additional 6 months. Consequently, a total of 21 patients were enrolled for long-term follow-up evaluation. The posttreatment follow-up period was 121 + or - 64 months (range, 31-254 months; median, 120 months). Three patients died of causes unrelated to hepatobiliary disease. The remaining patients were successfully followed up until this writing. The overall long-term success rate was 95% (20/21). No hepatobiliary malignancies developed within the follow-up period.
CONCLUSIONS: Endoscopic stent therapy is available for postoperative bile duct strictures. Long-term prognosis for more than 10 years is excellent. Repeat surgical interventions may be unavoidable in some cases, but endoscopic treatment should be proposed as the first-line treatment.

Entities:  

Mesh:

Year:  2010        PMID: 19730951     DOI: 10.1007/s00464-009-0673-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Biliary strictures: classification based on the principles of surgical treatment.

Authors:  H Bismuth; P E Majno
Journal:  World J Surg       Date:  2001-10       Impact factor: 3.352

Review 2.  Percutaneous balloon dilatation of benign biliary strictures.

Authors:  M C Morrison; M J Lee; S Saini; J A Brink; P R Mueller
Journal:  Radiol Clin North Am       Date:  1990-11       Impact factor: 2.303

Review 3.  Benign post-operative bile duct strictures.

Authors:  K D Lillemoe
Journal:  Baillieres Clin Gastroenterol       Date:  1997-12

4.  Long-term follow-up after biliary stent placement for postoperative bile duct stenosis.

Authors:  J J Bergman; L Burgemeister; M J Bruno; E A Rauws; D J Gouma; G N Tytgat; K Huibregtse
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

5.  Biliary stricture dilatation: multicenter review of clinical management in 73 patients.

Authors:  P R Mueller; E vanSonnenberg; J T Ferrucci; P J Weyman; R J Butch; R A Malt; H J Burhenne
Journal:  Radiology       Date:  1986-07       Impact factor: 11.105

6.  Benign biliary strictures: an analytic review (1970 to 1984).

Authors:  J F Genest; E Nanos; S Grundfest-Broniatowski; D Vogt; R E Hermann
Journal:  Surgery       Date:  1986-04       Impact factor: 3.982

7.  Classification of pancreatitis.

Authors:  M Sarner; P B Cotton
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

8.  Nonoperative management of benign postoperative biliary strictures.

Authors:  D J Gallacher; S Kadir; S L Kaufman; S E Mitchell; M L Kinnison; R Chang; P Adams; R I White; J L Cameron
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

9.  Management of benign biliary strictures: biliary enteric anastomosis vs endoscopic stenting.

Authors:  A Tocchi; G Mazzoni; G Liotta; G Costa; L Lepre; M Miccini; E De Masi; M A Lamazza; E Fiori
Journal:  Arch Surg       Date:  2000-02

10.  Long-term results of balloon dilation of benign bile duct strictures.

Authors:  L Suman; E M Civelli; G Cozzi; M Milella; R Meroni; R Vercelli; S Sala; A Severini
Journal:  Acta Radiol       Date:  2003-03       Impact factor: 1.701

View more
  5 in total

1.  The use of a 532-nm laser fitted with a balloon and a cylindrical light diffuser to treat benign biliary stricture: a pilot study.

Authors:  Jin-Seok Park; Seok Jeong; Don Haeng Lee; Joon Mee Kim; Sung Min Kim; Hyun Wook Kang
Journal:  Lasers Med Sci       Date:  2020-03-10       Impact factor: 3.161

Review 2.  The endoscopist and malignant and non-malignant biliary obstruction.

Authors:  S P Pereira; G Goodchild; G J M Webster
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-18       Impact factor: 5.187

Review 3.  Protocol for laparoscopic cholecystectomy: Is it rocket science?

Authors:  Tomohide Hori; Fumitaka Oike; Hiroaki Furuyama; Takafumi Machimoto; Yoshio Kadokawa; Toshiyuki Hata; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Maho Sasaki; Yusuke Kimura; Yuichiro Takamatsu; Masato Naito; Masaya Nakauchi; Takahiro Tanaka; Daigo Gunji; Kiyokuni Nakamura; Kiyoko Sato; Masahiro Mizuno; Taku Iida; Shintaro Yagi; Shinji Uemoto; Tsunehiro Yoshimura
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

Review 4.  Benign biliary strictures: prevalence, impact, and management strategies.

Authors:  Michael Xiang Ma; Vanoo Jayasekeran; Andre K Chong
Journal:  Clin Exp Gastroenterol       Date:  2019-02-18

5.  Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.

Authors:  Benjamin I Baarda; Ryszard A Zielke; Alaina K Holm; Aleksandra E Sikora
Journal:  mSphere       Date:  2021-02-03       Impact factor: 5.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.